What if Employers had a Convenient Way to Test for Cannabis Use?
October 11th, 2019
App, Exclusive, News, Top Story
With cannabis legalization sweeping across North America after decades of prohibition, there are some natural concerns surrounding the introduction of the drug to the legal marketplace. In the area of safety, most of the questions have surrounded the issue of impaired driving. One topic that hasn’t gotten a lot of press is that of workplace safety. The most widely-used, current workplace testing solution involves urinalysis, a cumbersome process that is often applied to screen applicants but is not necessarily practical for the detection of recent use on a regular basis.
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is actively developing the Cannabix Marijuana Breathalyzer, designed for roadside use by law enforcement officials. The company recently announced the licensing of patent-pending technology, developed by researchers at the University of British Columbia (UBC), that will be focused to offer a cannabis testing solution for workplace and even parental use. Recognizing that the requirements of potential end users vary greatly, Cannabix is looking to offer flexible solutions to meet the needs of a variety of markets.
Workplace Safety and Cannabis
In general, there is still much to be learned from scientific research into cannabis. This is an unsurprising side effect of nearly a century of cannabis prohibition, which greatly limited research on the plant. However, there is growing research that points to workplace issues surrounding cannabis.
A study of postal workers from 1992 showed that employees who tested positive for marijuana in pre-employment screening had significantly more accidents, injuries, and absenteeism compared with those who tested negative. Another study from 2010 pointed to the shortcomings of relying on pre-employment drug screening as a tool to improve workplace safety. Major conclusions included the fact that recent cannabis use (within 4 hours) led to impairment, something that urinalysis screening would not catch. Additionally, urinalysis was not shown to have a meaningful impact on job accident rates.
Parents have their own set of concerns. A 2008 study found that heavy adolescent use of marijuana negatively impacts attention, memory, and learning. A longitudinal study published in 2004 showed a correlation between cannabis use and lower educational attainment. As we have seen with the recent college admissions scandal, there are definitely pressures to do whatever it takes to help children succeed. Being able to conveniently test for marijuana use probably lies at the least invasive, ethically clean end of the spectrum of potential parental actions.
Marijuana Breathalyzer technologies
Cannabix Technologies recognizes the varying needs of the wide range of its potential clients as it develops reliable and portable cannabis testing units. As a first step, the company knows that everyone would prefer a test that doesn’t have to be sent to a lab to analyze results. The breathalyzer model is universally preferred as well, when compared to tests that require the collection of bodily fluids. From that basis, needs start to diverge.
Roadside breathalyzers need to work in all manner of environmental conditions, be rugged and accurate, returning results that will eventually hold up in court. Workplace and parental users will usually be operating in much more controlled environments, and the scrutiny of the results will usually not rise to the level of court proceedings. There is price sensitivity between the markets as well. Employers want to know if someone can safely do their job, and parents want to know if their child has been smoking marijuana before getting behind the wheel of the family car.
Cannabix’s THC Breath Analyzer.
The Cannabix Marijuana Breathalyzer uses field asymmetric waveform ion mobility spectrometry (FAIMS) technology to detect THC from breath samples. FAIMS is an analytical chemistry technology that filters and identifies substances by separating ions. It has the ability to connect directly with Mass Spectrometry technology to confirm its highly sensitive roadside results in the lab, improving the chance that the results stand up in the courts. The THC Breath Analyzer utilizes lower-cost yet highly-effective, versatile, microfluidic sensors that can provide results quickly and cost efficiently.
As with any product company, Cannabix is analyzing the needs of its potential target markets and developing products with features to match those markets. The recent licensing announcement greatly expands the company’s potential client base, and the company expects the resulting THC Breath Analyzer to be available for expanded testing soon, so keep an eye out for further developments as Cannabix Technologies does its part to solve some of the public safety concerns surrounding cannabis use behind the wheel, on the job, and amongst adolescents.
About CFN Media
For Visitors and Viewers
CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.
For Cannabis Businesses & Companies
CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.
Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.
Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.